Share this video  

VJHemOnc is committed to improving our service to you

MPN Congress 2022 | Optimizing current JAK2 inhibitors in myelofibrosis

Srdan Verstovsek, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives a presentation on optimizing current JAK2 inhibitors in myelofibrosis (MF) at the 14th International Congress on Myeloproliferative Neoplasms held in New York City, NY.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter